Valuation dashboard for IRIDEX Corporation (IRIX) with P/E N/A, P/B 2.90, EV/EBITDA -6.71 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment.
Analysis Summary
IRIDEX Corporation reported revenue of $52.7M in the most recent fiscal year, growing at a 5-year CAGR of 7.7%.
Trailing-twelve-month margins: gross margin 36.2%, operating margin -5.4%, net margin -6.9%.
At the current price of $0.61, IRIX has negative trailing earnings (P/E not meaningful) and an ROE of -78.94%. Market capitalisation stands at $11M.
Balance sheet quality for IRIX: current ratio of 1.9. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 2.90 |
| EV / EBITDA | -6.71 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-6.31 |
| vs Current Price | -1138.9% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| IRIX | IRIDEX Corporation | $11M | 2.90 | -78.9% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $0.61 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -78.94% |
| Return on Invested Capital | -19.53% |
| Return on Assets | -13.01% |
| Gross Margin | 36.23% |
| Operating Margin | -5.39% |
| Net Margin | -6.88% |
Related companies: ADGM · ALUR · ASBP · COCH · HOTH · IINN · NVNO
Explore sector: Healthcare · Medical - Devices
More sections of IRIX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks